Recent Stories
Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: RobotsBlack October Wasn't an Attack Wave. It Was a Warning.Extreme Ownership Means Ultimate Achievement – NASA Culture Shift
← Back to the board
Money

HHS ASPR awarded MAPP Biopharmaceutical contract 75A50122C00061 for therapeutics against Ebola, Sudan and Marburg viruses.

Why it’s here: A $220M ASPR/BARDA-style procurement of therapeutics for Ebola, Sudan and Marburg viruses is squarely within the biotechnology policy area (biosecurity and pandemic preparedness via ASPR).

Trace across the board

Item

Connected

12 links

About

  • Department of Health and Human Services

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

HHS ASPR awarded MAPP Biopharmaceutical contract 75A50122C00061 for therapeutics against Ebola, Sudan and Marburg viruses. — The Wave